Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/). Led by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.


MaggiesCentreOx2.jpg

The Department of Oncology teamed-up with The Oxford Maggie’s Centre to mark the day with a ‘Science on the Sofa’ chat about Immunotherapy. 

 

We met a group of health professionals and patients from the Churchill Hospital to talk about the science behind immunotherapy and explore how the Department of Oncology is contributing to making immunotherapy more effective and deliver on the promise of this amazing new science.

 

It was a real privilege meet people who have cancer and the people who treat and support them.  The Maggie’s Centre is a beautiful place with all of the comforting calm of the treehouse it closely resembles. 

 

Thank you Claire Marriot for helping create this opportunity.

 

MaggiesOxLogo.png

 

Similar stories

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana has found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Further funding secured to hunt out cancer using innovative radiotherapy techniques

Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy despite lockdown.

Reprogramming tumour cells using an antimalarial drug

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.